nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—L-DOPA—Liothyronine—hypothyroidism	0.797	1	CrCrCtD
Methyldopa—DDC—Amine-derived hormones—IYD—hypothyroidism	0.0177	0.235	CbGpPWpGaD
Methyldopa—DDC—Amine-derived hormones—TPO—hypothyroidism	0.0142	0.188	CbGpPWpGaD
Methyldopa—Distention—Liotrix—hypothyroidism	0.0117	0.148	CcSEcCtD
Methyldopa—DDC—nerve—hypothyroidism	0.00967	0.199	CbGeAlD
Methyldopa—DDC—Amine-derived hormones—TSHB—hypothyroidism	0.00656	0.087	CbGpPWpGaD
Methyldopa—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00612	0.0771	CcSEcCtD
Methyldopa—DDC—Amine-derived hormones—SLC5A5—hypothyroidism	0.00491	0.0651	CbGpPWpGaD
Methyldopa—Angina pectoris—Liothyronine—hypothyroidism	0.00467	0.0588	CcSEcCtD
Methyldopa—Tenderness—Liotrix—hypothyroidism	0.00317	0.0399	CcSEcCtD
Methyldopa—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00301	0.0378	CcSEcCtD
Methyldopa—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00301	0.0378	CcSEcCtD
Methyldopa—DDC—adrenal gland—hypothyroidism	0.00268	0.0551	CbGeAlD
Methyldopa—Lightheadedness—Liotrix—hypothyroidism	0.00247	0.0311	CcSEcCtD
Methyldopa—DDC—Amino acid and derivative metabolism—IYD—hypothyroidism	0.00247	0.0327	CbGpPWpGaD
Methyldopa—COMT—adrenal cortex—hypothyroidism	0.00246	0.0505	CbGeAlD
Methyldopa—DDC—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00244	0.0323	CbGpPWpGaD
Methyldopa—COMT—heart—hypothyroidism	0.00237	0.0488	CbGeAlD
Methyldopa—Angina pectoris—Levothyroxine—hypothyroidism	0.00229	0.0289	CcSEcCtD
Methyldopa—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00229	0.0289	CcSEcCtD
Methyldopa—COMT—cardiovascular system—hypothyroidism	0.00224	0.0461	CbGeAlD
Methyldopa—DDC—testis—hypothyroidism	0.00222	0.0456	CbGeAlD
Methyldopa—Cardiac failure congestive—Liotrix—hypothyroidism	0.00221	0.0278	CcSEcCtD
Methyldopa—Body temperature increased—Liothyronine—hypothyroidism	0.00216	0.0272	CcSEcCtD
Methyldopa—DDC—liver—hypothyroidism	0.0021	0.0431	CbGeAlD
Methyldopa—COMT—gonad—hypothyroidism	0.00203	0.0418	CbGeAlD
Methyldopa—COMT—pituitary gland—hypothyroidism	0.00198	0.0408	CbGeAlD
Methyldopa—DDC—Amino acid and derivative metabolism—TPO—hypothyroidism	0.00197	0.0262	CbGpPWpGaD
Methyldopa—COMT—adrenal gland—hypothyroidism	0.00177	0.0364	CbGeAlD
Methyldopa—COMT—blood—hypothyroidism	0.00177	0.0364	CbGeAlD
Methyldopa—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.00177	0.0234	CbGpPWpGaD
Methyldopa—Abdominal distension—Liotrix—hypothyroidism	0.00174	0.022	CcSEcCtD
Methyldopa—COMT—thyroid gland—hypothyroidism	0.00171	0.0352	CbGeAlD
Methyldopa—Angina pectoris—Liotrix—hypothyroidism	0.00169	0.0213	CcSEcCtD
Methyldopa—COMT—female gonad—hypothyroidism	0.00165	0.034	CbGeAlD
Methyldopa—DDC—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00157	0.0208	CbGpPWpGaD
Methyldopa—SLC15A1—liver—hypothyroidism	0.00156	0.032	CbGeAlD
Methyldopa—COMT—testis—hypothyroidism	0.00147	0.0301	CbGeAlD
Methyldopa—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—hypothyroidism	0.00145	0.0192	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00145	0.0192	CbGpPWpGaD
Methyldopa—Arthralgia—Dextrothyroxine—hypothyroidism	0.0014	0.0176	CcSEcCtD
Methyldopa—Arthralgia—Levothyroxine—hypothyroidism	0.0014	0.0176	CcSEcCtD
Methyldopa—COMT—liver—hypothyroidism	0.00139	0.0285	CbGeAlD
Methyldopa—COMT—cerebellum—hypothyroidism	0.00135	0.0278	CbGeAlD
Methyldopa—DDC—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00134	0.0178	CbGpPWpGaD
Methyldopa—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00122	0.0154	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00122	0.0154	CcSEcCtD
Methyldopa—ADRA2A—heart—hypothyroidism	0.00121	0.0249	CbGeAlD
Methyldopa—Flatulence—Liotrix—hypothyroidism	0.00119	0.015	CcSEcCtD
Methyldopa—COMT—Neuronal System—SLC5A7—hypothyroidism	0.00111	0.0147	CbGpPWpGaD
Methyldopa—Body temperature increased—Levothyroxine—hypothyroidism	0.00106	0.0133	CcSEcCtD
Methyldopa—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00106	0.0133	CcSEcCtD
Methyldopa—ADRA2A—gonad—hypothyroidism	0.00104	0.0213	CbGeAlD
Methyldopa—Arthralgia—Liotrix—hypothyroidism	0.00103	0.0129	CcSEcCtD
Methyldopa—ADRA2A—pituitary gland—hypothyroidism	0.00101	0.0208	CbGeAlD
Methyldopa—Oedema—Liotrix—hypothyroidism	0.000986	0.0124	CcSEcCtD
Methyldopa—Infection—Liotrix—hypothyroidism	0.000979	0.0123	CcSEcCtD
Methyldopa—Asthenia—Levothyroxine—hypothyroidism	0.000961	0.0121	CcSEcCtD
Methyldopa—Asthenia—Dextrothyroxine—hypothyroidism	0.000961	0.0121	CcSEcCtD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000952	0.0126	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000931	0.0124	CbGpPWpGaD
Methyldopa—Diarrhoea—Levothyroxine—hypothyroidism	0.000917	0.0115	CcSEcCtD
Methyldopa—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000917	0.0115	CcSEcCtD
Methyldopa—DDC—Amino acid and derivative metabolism—TSHB—hypothyroidism	0.000913	0.0121	CbGpPWpGaD
Methyldopa—ADRA2A—adrenal gland—hypothyroidism	0.000903	0.0186	CbGeAlD
Methyldopa—ADRA2A—blood—hypothyroidism	0.000902	0.0186	CbGeAlD
Methyldopa—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000898	0.0113	CcSEcCtD
Methyldopa—Paraesthesia—Liotrix—hypothyroidism	0.000885	0.0111	CcSEcCtD
Methyldopa—ADRA2A—thyroid gland—hypothyroidism	0.000871	0.0179	CbGeAlD
Methyldopa—Vomiting—Dextrothyroxine—hypothyroidism	0.000852	0.0107	CcSEcCtD
Methyldopa—Vomiting—Levothyroxine—hypothyroidism	0.000852	0.0107	CcSEcCtD
Methyldopa—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.000852	0.0113	CbGpPWpGaD
Methyldopa—Rash—Levothyroxine—hypothyroidism	0.000845	0.0106	CcSEcCtD
Methyldopa—Rash—Dextrothyroxine—hypothyroidism	0.000845	0.0106	CcSEcCtD
Methyldopa—Dermatitis—Dextrothyroxine—hypothyroidism	0.000844	0.0106	CcSEcCtD
Methyldopa—Dermatitis—Levothyroxine—hypothyroidism	0.000844	0.0106	CcSEcCtD
Methyldopa—Constipation—Liotrix—hypothyroidism	0.000843	0.0106	CcSEcCtD
Methyldopa—ADRA2A—female gonad—hypothyroidism	0.000842	0.0173	CbGeAlD
Methyldopa—Headache—Dextrothyroxine—hypothyroidism	0.000839	0.0106	CcSEcCtD
Methyldopa—Headache—Levothyroxine—hypothyroidism	0.000839	0.0106	CcSEcCtD
Methyldopa—Nausea—Dextrothyroxine—hypothyroidism	0.000796	0.01	CcSEcCtD
Methyldopa—Nausea—Levothyroxine—hypothyroidism	0.000796	0.01	CcSEcCtD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000789	0.0105	CbGpPWpGaD
Methyldopa—Body temperature increased—Liotrix—hypothyroidism	0.000779	0.00981	CcSEcCtD
Methyldopa—ADRA2A—testis—hypothyroidism	0.000746	0.0153	CbGeAlD
Methyldopa—Hypersensitivity—Liotrix—hypothyroidism	0.000726	0.00914	CcSEcCtD
Methyldopa—COMT—Neuronal System—NEFL—hypothyroidism	0.000714	0.00947	CbGpPWpGaD
Methyldopa—Asthenia—Liotrix—hypothyroidism	0.000707	0.0089	CcSEcCtD
Methyldopa—ADRA2A—cerebellum—hypothyroidism	0.000689	0.0142	CbGeAlD
Methyldopa—DDC—Amino acid and derivative metabolism—SLC5A5—hypothyroidism	0.000684	0.00907	CbGpPWpGaD
Methyldopa—Diarrhoea—Liotrix—hypothyroidism	0.000674	0.00849	CcSEcCtD
Methyldopa—Dizziness—Liotrix—hypothyroidism	0.000652	0.0082	CcSEcCtD
Methyldopa—Vomiting—Liotrix—hypothyroidism	0.000627	0.00789	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000625	0.00829	CbGpPWpGaD
Methyldopa—Rash—Liotrix—hypothyroidism	0.000621	0.00782	CcSEcCtD
Methyldopa—Dermatitis—Liotrix—hypothyroidism	0.000621	0.00782	CcSEcCtD
Methyldopa—Headache—Liotrix—hypothyroidism	0.000617	0.00777	CcSEcCtD
Methyldopa—Nausea—Liotrix—hypothyroidism	0.000585	0.00737	CcSEcCtD
Methyldopa—DDC—Circadian rythm related genes—AVP—hypothyroidism	0.00051	0.00677	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000484	0.00642	CbGpPWpGaD
Methyldopa—DDC—Metabolism—IYD—hypothyroidism	0.000453	0.00601	CbGpPWpGaD
Methyldopa—COMT—Metabolism—IYD—hypothyroidism	0.000402	0.00534	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000401	0.00532	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ATP5O—hypothyroidism	0.000385	0.00511	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000381	0.00505	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TPO—hypothyroidism	0.000362	0.00481	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ATP5O—hypothyroidism	0.000342	0.00454	CbGpPWpGaD
Methyldopa—COMT—Biological oxidations—POMC—hypothyroidism	0.000341	0.00452	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TPO—hypothyroidism	0.000322	0.00427	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.0003	0.00398	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00024	0.00319	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000214	0.00284	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000214	0.00284	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000193	0.00257	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—TRH—hypothyroidism	0.000183	0.00243	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000173	0.0023	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TSHB—hypothyroidism	0.000168	0.00222	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—TSHB—hypothyroidism	0.000163	0.00217	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—TSHR—hypothyroidism	0.000163	0.00217	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—IYD—hypothyroidism	0.00016	0.00212	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000152	0.00202	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PIK3C2A—hypothyroidism	0.000149	0.00198	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TSHB—hypothyroidism	0.000149	0.00198	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ATP5O—hypothyroidism	0.000136	0.0018	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PIK3C2A—hypothyroidism	0.000133	0.00176	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SH2B3—hypothyroidism	0.00013	0.00173	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TPO—hypothyroidism	0.000128	0.0017	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000126	0.00168	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SLC5A5—hypothyroidism	0.000126	0.00167	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SLC5A5—hypothyroidism	0.000111	0.00148	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000107	0.00142	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—POMC—hypothyroidism	0.000106	0.0014	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—TRH—hypothyroidism	0.000103	0.00137	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—AVP—hypothyroidism	9.62e-05	0.00128	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	9.4e-05	0.00125	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	9.22e-05	0.00122	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	9.22e-05	0.00122	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—VAV3—hypothyroidism	8.93e-05	0.00118	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.39e-05	0.00111	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	8.38e-05	0.00111	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	8.38e-05	0.00111	CbGpPWpGaD
Methyldopa—DDC—Metabolism—POMC—hypothyroidism	6.57e-05	0.000871	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	6.42e-05	0.000852	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	6.39e-05	0.000848	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TSHB—hypothyroidism	5.92e-05	0.000785	CbGpPWpGaD
Methyldopa—COMT—Metabolism—POMC—hypothyroidism	5.83e-05	0.000774	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	5.64e-05	0.000749	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TRH—hypothyroidism	5.55e-05	0.000736	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IGF1—hypothyroidism	5.5e-05	0.000729	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	5.44e-05	0.000721	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	5.27e-05	0.0007	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	5.12e-05	0.00068	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	4.95e-05	0.000656	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	4.95e-05	0.000656	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	4.94e-05	0.000655	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SLC5A5—hypothyroidism	4.43e-05	0.000588	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	4.41e-05	0.000585	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	3.61e-05	0.000479	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	3.28e-05	0.000435	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRL—hypothyroidism	3.27e-05	0.000434	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	3.03e-05	0.000402	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AVP—hypothyroidism	2.92e-05	0.000387	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—POMC—hypothyroidism	2.32e-05	0.000307	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—POMC—hypothyroidism	1.94e-05	0.000257	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	1.86e-05	0.000247	CbGpPWpGaD
